← 產業報告目錄
Endothelial Dysfunction Market Size, Share & Trends Analysis Report By Cause (Hypertension, Diabetes, Hypercholesterolemia, Baches’s disease, Obesity, Others), By Test Type (Invasive, Non-invasive tests), By End-User, By Region, And By Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-28頁數 179報告編號 INSIGHTACE-7356d52f7e
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2022 valuation of USD 1.84 Bn, the global Endothelial Dysfunction Market is projected to accelerate to USD 2.63 Bn by 2031, demonstrating a CAGR of 4.1% during the 2023–2031 forecast window.
The Endothelial Dysfunction sector involves a condition characterised by impaired or compromised functioning of the inner lining of blood vessels, the endothelium. This domain has witnessed marked transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is propelled by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Endothelial Dysfunction Market Snapshot
Chapter 4. Global Endothelial Dysfunction Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Cause Estimates & Trend Analysis
5.1. By Cause, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Cause:
5.2.1. Hypertension
5.2.2. Diabetes
5.2.3. Hypercholestrolaemia
5.2.4. Bechet's Disease
5.2.5. Obesity
5.2.6. Others
Chapter 6. Market Segmentation 2: By Test Type Estimates & Trend Analysis
6.1. By Test Type & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Test Type:
6.2.1. Invasive Tests
6.2.2. Non-Invasive Tests
6.2.2.1. Flow Mediated Dilatory
6.2.2.2. Peripheral Arterial Tonometry (PAT)
6.2.2.3. Venous Occlusion Pletismography
6.2.2.4. Circulating Markers
6.2.2.5. Others
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:
7.2.1. Hospitals
7.2.2. Ambulatory Surgery Centers
7.2.3. Specialty Clinics
7.2.4. Others
Chapter 8. Endothelial Dysfunction Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Endothelial Dysfunction Market revenue (US$ Million) estimates and forecasts By Cause, 2019-2031
8.1.2. North America Endothelial Dysfunction Market revenue (US$ Million) estimates and forecasts By Test Type, 2019-2031
8.1.3. North America Endothelial Dysfunction Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
8.1.4. North America Endothelial Dysfunction Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Endothelial Dysfunction Market revenue (US$ Million) By Cause, 2019-2031
8.2.2. Europe Endothelial Dysfunction Market revenue (US$ Million) By Test Type, 2019-2031
8.2.3. Europe Endothelial Dysfunction Market revenue (US$ Million) By End User, 2019-2031
8.2.4. Europe Endothelial Dysfunction Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Endothelial Dysfunction Market revenue (US$ Million) By Cause, 2019-2031
8.3.2. Asia Pacific Endothelial Dysfunction Market revenue (US$ Million) By Test Type, 2019-2031
8.3.3. Asia Pacific Endothelial Dysfunction Market revenue (US$ Million) By End User, 2019-2031
8.3.4. Asia Pacific Endothelial Dysfunction Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Endothelial Dysfunction Market revenue (US$ Million) By Cause, (US$ Million) 2019-2031
8.4.2. Latin America Endothelial Dysfunction Market revenue (US$ Million) By Test Type, (US$ Million) 2019-2031
8.4.3. Latin America Endothelial Dysfunction Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
8.4.4. Latin America Endothelial Dysfunction Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Endothelial Dysfunction Market revenue (US$ Million) By Cause, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Endothelial Dysfunction Market revenue (US$ Million) By Test Type, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Endothelial Dysfunction Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Endothelial Dysfunction Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ZOLL Medical Corp,
9.2.2. Sphingo Tec GmbH,
9.2.3. Lawrence Berkeley National Laboratory,
9.2.4. The Polymath Co,
9.2.5. Endothelix Inc,
9.2.6. Perimed AB,
9.2.7. SMART Medical Ltd,
9.2.8. Everist Health Inc,
9.2.9. Alam Medical SaRl,
9.2.10. Medizinische Messtechnik GmbH
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們